Indianapolis Business Journal

A long-planned, $92 million mixed-use redevelopment project—the first of its kind in this city of 64,000—is taking shape on a 19-acre site in downtown Greenwood, starting with a city-owned sports fieldhouse. Susan Orr outlines the strategy behind The Madison and reinvigorating Greenwood’s core. Also in this week’s issue, John Russell has all the details about Eli Lilly and Co.’s new weight loss drug, tirzepatide, which has performed spectacularly well in clinical trials and could boost Lilly’s top line by $5 billion per year. And Leslie Bonilla Muñiz examines how a 13-member state task force plans to address Indiana’s affordable housing shortage, in large part by rethinking regulations that builders and critics say drive up construction costs.